CTIS.eu › Cities › France › Tours Cedex 9
Tours Cedex 9
France
208 total trials
98 recruiting
2025-522996-27-00
5
2026-05-05
recurrent and/or metastatic squamous cell carcinoma of the head and ne
2025-520466-22-00
5
2026-04-29
Advanced Platinum-resistant Epithelial Ovarian Cancer
2024-515635-30-00
3
2026-03-24
Coagulopathy
2023-507097-41-01
5
2025-03-20
Patients with limited-stage small cell lung cancer (LS-SCLC)
without
2024-512536-29-00
4
2025-02-28
Amyotrophic Lateral Sclerosis (ALS)
2022-502825-17-00
4
2024-10-07
Melanoma
2023-504214-30-00
5
2024-06-27
Metastatic Castration-Sensitive Prostate Cancer (mCSPC)
2022-502660-20-00
5
2024-01-23
Follicular lymphoma
2023-504670-38-00
4
2023-11-17
Extensive disease Small Cell Lung Cancer
2024-512483-59-00
5
2023-06-09
Improvement of cardiovascular outcomes in patients with advanced
chron
2022-500479-29-00
10
2023-03-28
International Prognostic Scoring System-Revised (IPSS-R) Low - or Inte
2023-507031-38-00
5
2023-01-09
Severe viral lung infections
2024-511267-28-00
5
2021-02-17
B-cell malignancies
2024-511855-16-00
5
2019-07-25
Onco-hematology
2023-505046-26-00
5
2026-05-07
Colon carcinoma
2025-523123-22-00
5
2026-05-07
Chronic Kidney Disease
2024-517674-23-00
5
2026-04-09
Subjects undergoing elective endovascular coiling-only repair of unrup
2025-522232-13-00
4
2026-03-06
Sepsis-associated acute kidney injury (AKI)
2024-520128-27-00
4
2026-03-04
colorectal adenocarcinoma
2025-522960-34-00
5
2026-02-09
Established cardiovascular disease
2024-519554-37-00
5
2026-01-16
Phenylketonuria
2024-514997-27-00
4
2025-12-18
cell penile carcinoma
2024-518385-26-01
5
2025-12-18
Polymyalgia Rheumatica (PMR)
2025-522860-34-00
5
2025-12-16
Chronic lymphocytic leukemia (CLL)
Showing 25–48 of 208 trials